Real Chemistry reported $270 million in global sales for the first six months of this year, this is an increase of over 20% when compared the previous year’s statistics. Real Chemistry is therefore expected to achieve organic growth of over 20% in 2022.
Chief Executive Officer at Real Chemistry, Shankar Narayanan commented that "during the first half of this year” the company is increasing “innovation between our integrated teams by bringing together AI and creative ideas which are driving stronger results for our clients. Together, we're reaching patients and healthcare providers in more targeted, impactful ways and creating better healthcare experiences.”
“Real Chemistry reported $270 million in global sales for the first six months of this year“
High value investments have been injected into its data and AI range, commercial and communications service contributions, employee initiatives, and operational infrastructure.
ConversationHealth’s CEO, Dr. John Reeves, commented that RealChemilstry purchased ConversationHealth, an AI shop, six months ago. ConversationHealth aims to increase and develop interactions between healthcare professionals, pharmaceutical firms, and consumers.
Real Chemistry has recently taken a new approach to staff benefits, with a new employee appreciation programme. However, quite ironically, the business cut 50 employees from their workforce earlier in the year.
On a positive note, they have appointed a number of new senior employees, such as Andy Johnson as chief information officer, and Wendy Carhart as chief communications, culture, and purpose officer.
Real Chemistry experienced a 35% increase in sales revenue across the United States last year, reaching almost $440 million. to $439 million. In the same period, their global sales climbed by 36% to $475 million.
© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.See all the latest jobs in Healthcare Communications